Table 1.
Study population.
| Hypertensive patients N = 50 | Healthy controls N = 25 | ||||
|---|---|---|---|---|---|
| Median/N | Interquartile range/% | Median/N | Interquartile range/% | P-value | |
| Age [years] | 66 | 57–72 | 61 | 54–65 | 0.018 |
| Sex (male) | 38 | 76% | 14 | 56% | 0.111 |
| In partnership | 41 | 85% | 19 | 76% | 0.347 |
| Higher education | 12 | 24% | 10 | 4% | 0.183 |
| Physical activity >500 MET-min/week | 43 | 86% | 23 | 92% | 0.768 |
| BMI [kg/m2] | 28.1 | 26.3–31.3 | 24.3 | 22.7–27.4 | <0.001 |
| HADS anxious symptoms | 6 | 2–8 | 6 | 1.5–7 | 0.566 |
| HADS severe anxious symptoms | 4 | 8% | 0 | 0 | 0.590 |
| HADS depressive symptoms | 4 | 2–8 | 3 | 1.5–5 | 0.130 |
| HADS severe depressive symptoms | 6 | 12% | 0 | 0 | 0.354 |
| Systolic blood pressure [mmhg] (rest) | 133.0 | 127.3–142.1 | 129 | 121.5–140.0 | 0.222 |
| Diastolic blood pressure [mmhg] (rest) | 78.8 | 75.8–83.6 | 79.5 | 73.0–88.0 | 0.800 |
| Heart rate [bpm] (rest) | 60.4 | 56.2–67.8 | 59.6 | 57.0–65.0 | 0.783 |
| Number of diagnoses | 6 | 4–7 | 0 | 0 | |
| Number of medication | 7 | 5–9 | 0 | 0 | |
| Number of antihypertensive medication | 3 | 2–4 | 0 | 0 | |
| Coronary artery disease | 37 | 74% | 0 | 0 | |
| History of myocardial infarction | 20 | 40% | 0 | 0 | |
| Obesity (BMI>30 kg/m2) | 19 | 38% | 0 | 0 | |
| Diabetes | 13 | 26% | 0 | 0 | |
| Smoking | 4 | 8% | 0 | 0 | |
| Medication: | |||||
| ACE Inhibitor/AT1 Receptor Antagonist (mostly Ramipril/Candesartan) | 48 | 96% | 0 | 0 | |
| Beta-blocking agent (mostly Metoprolol) | 39 | 78% | 0 | 0 | |
| Diuretics (mostly Hydrochlorothiazid) | 25 | 50% | 0 | 0 | |
| Calcium channel blocker (mostly Amlodipin) | 24 | 48% | 0 | 0 | |
P-values calculated with Mann Whitney U-test for metric and chi square test for dichotomous variables.